文献速递胸部肿瘤

黑人与白人肺癌患者突变患病率及类型的比较

Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.
PubMed 文献 · JAMA Oncol · 2017-01-01

该研究收集美国Baptist癌症中心9年间509例肺癌肿瘤标本(319例腺癌、142例鳞状细胞癌),对504个癌症基因进行大规模平行测序,比较黑人与白人患者体细胞变异频率。校正多重假设检验后,两种肿瘤类型中总体突变频率和拷贝数变化在黑人与白人之间均无显著差异,EGFR和KRAS等受体酪氨酸激酶/Ras/Raf通路成员的特定激活变异在肺腺癌中亦无显著差异。

要点

  • 校正多重假设检验后,腺癌和鳞癌中黑人与白人总体突变频率及拷贝数变化无显著差异
  • 肺腺癌中EGFR、KRAS等受体酪氨酸激酶/Ras/Raf通路激活变异在黑人与白人之间无显著差异
  • 黑人患者肺癌的临床可操作基因组变异与白人患者相似,靶向治疗临床试验可能使两组患者均显著获益

核心结论

  • 黑人患者肺癌在临床可操作基因组变异方面与白人患者相似,靶向治疗临床试验可能使两组患者均显著获益。

研究设计与样本

  • 肿瘤标本于2004年1月至2012年12月共9年间收集自Baptist癌症中心(田纳西州孟菲斯)。
  • 在Dana-Farber癌症研究所(马萨诸塞州波士顿)对504个癌症基因进行大规模平行测序基因组分析。
  • 共分析509例肺癌肿瘤标本(319例腺癌;142例鳞状细胞癌),来自245例黑人患者和264例白人患者。

主要发现

  • 共收集并分析509例肺癌(273例女性[129例黑人、144例白人]和236例男性[116例黑人、120例白人])。
  • 在313例腺癌和138例鳞状细胞癌中,校正多重假设检验后,黑人与白人之间总体突变频率和拷贝数变化在两种肿瘤类型中均无显著差异。
  • 肺腺癌中EGFR和KRAS等受体酪氨酸激酶/Ras/Raf通路成员的特定激活变异在黑人与白人之间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Lung cancer is the leading cause of cancer death in the United States in all ethnic and racial groups. The overall death rate from lung cancer is higher in black patients than in white patients. OBJECTIVE: To compare the prevalence and types of somatic alterations between lung cancers from black patients and white patients. Differences in mutational frequencies could illuminate differences in prognosis and lead to the reduction of outcome disparities by more precisely targeting patients' treatment. DESIGN, SETTING, AND PARTICIPANTS: Tumor specimens were collected from Baptist Cancer Center (Memphis, Tennessee) over the course of 9 years (January 2004-December 2012). Genomic analysis by massively parallel sequencing of 504 cancer genes was performed at Dana-Farber Cancer Institute (Boston, Massachusetts). Overall, 509 lung cancer tumors specimens (319 adenocarcinomas; 142 squamous cell carcinomas) were profiled from 245 black patients and 264 white patients. MAIN OUTCOMES AND MEASURES: The frequencies of genomic alterations were compared between tumors from black and white populations. RESULTS: Overall, 509 lung cancers were collected and analyzed (273 women [129 black patients; 144 white patients] and 236 men [116 black patients; 120 white patients]). Using 313 adenocarcinomas and 138 squamous cell carcinomas with genetically supported ancestry, overall mutational frequencies and copy number changes were not significantly different between black and white populations in either tumor type after correcting for multiple hypothesis testing. Furthermore, specific activating alterations in members of the receptor tyrosine kinase/Ras/Raf pathway including EGFR and KRAS were not significantly different between populations in lung adenocarcinoma. CONCLUSIONS AND RELEVANCE: These results demonstrate that lung cancers from black patients are similar to cancers from white patients with respect to clinically actionable genomic alterations and suggest that clinical trials of targeted therapies could significantly benefit patients in both groups.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Campbell JD, Lathan C, Sholl L, et al. Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations. JAMA Oncol. 2017. PMID: 28114446. doi:10.1001/jamaoncol.2016.6108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。